Superworth

Iovance Biotherapeutics market cap IOVA

Share price times shares outstanding: what the whole company sells for, since 2011.

Today, Nov 2, 2026
$3.6B
Highest close in our data
$7.5B
Jan 2021

Iovance Biotherapeutics is worth $3.6B at the close on Nov 2, 2026, at $8.02 a share.

That is up 298% over the last year and down 7% over five years.

Its highest close in our data was $7.5B in Jan 2021.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$3.6B$936.8M$6.6B+221%
2025$1.1B$554.3M$2.3B−50%
2024$2.2B$1.9B$4.7B+8%
2023$2.1B$825.1M$2.1B+106%
2022$1B$966M$2.9B−66%
2021$3B$2.6B$7.5B−56%
2020$6.8B$2.7B$7.3B+94%
2019$3.5B$1.1B$3.7B+217%
2018$1.1B$606.5M$1.7B+91%
2017$581.1M$294.6M$657.3M+35%
2016$431.5M$222.9M$537.6M+17%
2015$369.3M$201.8M$599.1M+60%
2014$230.5M$92.4M$236M+9%
2013$211.6M$782.9K$211.6M+1490%
2012$13.3M$12.5M$99.4M−82%
2011$73.6M$69.9M$106.4Mn/a

Against its peers

Companies in Biotechnology nearest Iovance Biotherapeutics' size, closest first, today.

CompanyMarket cap
IOVAIovance Biotherapeutics$3.6B
ADMAAdma Biologics$2.5B
VCELVericel$2.1B
KRYSKrystal Biotech$8.8B
RGENRepligen$9.8B
TECHBIO-TECHNE$11.4B
HALOHalozyme Therapeutics$14.6B
MGTXMeiraGTx$895.1M
NBIXNeurocrine Biosciences$14.8B
EXELExelixis$17.4B
ALNYAlnylam Pharmaceuticals$21.2B
Peer median$10.6B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Iovance Biotherapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.